Mohsen Afarideh

69.9k total citations
64 papers, 1.5k citations indexed

About

Mohsen Afarideh is a scholar working on Epidemiology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mohsen Afarideh has authored 64 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 13 papers in Molecular Biology and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mohsen Afarideh's work include Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Blood Pressure and Hypertension Studies (4 papers). Mohsen Afarideh is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Blood Pressure and Hypertension Studies (4 papers). Mohsen Afarideh collaborates with scholars based in Iran, United States and Taiwan. Mohsen Afarideh's co-authors include Alireza Esteghamati, Alireza Ghajar, Sina Noshad, Manouchehr Nakhjavani, Shahin Akhondzadeh, Behnam Heidari, Jeffrey I. Mechanick, Elias Khajeh, Morsaleh Ganji and Mohammad Saadat and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Hypertension.

In The Last Decade

Mohsen Afarideh

63 papers receiving 1.4k citations

Peers

Mohsen Afarideh
Mohsen Afarideh
Citations per year, relative to Mohsen Afarideh Mohsen Afarideh (= 1×) peers Aleksander Owczarek

Countries citing papers authored by Mohsen Afarideh

Since Specialization
Citations

This map shows the geographic impact of Mohsen Afarideh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohsen Afarideh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohsen Afarideh more than expected).

Fields of papers citing papers by Mohsen Afarideh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohsen Afarideh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohsen Afarideh. The network helps show where Mohsen Afarideh may publish in the future.

Co-authorship network of co-authors of Mohsen Afarideh

This figure shows the co-authorship network connecting the top 25 collaborators of Mohsen Afarideh. A scholar is included among the top collaborators of Mohsen Afarideh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohsen Afarideh. Mohsen Afarideh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Afarideh, Mohsen, et al.. (2024). Dermatologic manifestations in pediatric patients with inflammatory bowel disease. Pediatric Dermatology. 41(2). 234–242. 2 indexed citations
2.
Afarideh, Mohsen, Roman Thaler, Farzaneh Khani, et al.. (2020). Global epigenetic alterations of mesenchymal stem cells in obesity: the role of vitamin C reprogramming. Epigenetics. 16(7). 705–717. 16 indexed citations
3.
Afarideh, Mohsen, Zahra Aryan, Alireza Ghajar, et al.. (2019). Association of non-alcoholic fatty liver disease with microvascular complications of type 2 diabetes. Primary care diabetes. 13(6). 505–514. 26 indexed citations
4.
Ghajar, Alireza, et al.. (2018). l -Carnosine as Adjunctive Therapy in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Journal of Child and Adolescent Psychopharmacology. 28(5). 331–338. 19 indexed citations
5.
Khaloo, Pegah, Hamid Alemi, Mohammad Alì Mansournia, et al.. (2018). Sitagliptin vs. pioglitazone as add-on treatments in patients with uncontrolled type 2 diabetes on the maximal dose of metformin plus sulfonylurea. Journal of Endocrinological Investigation. 42(7). 851–857. 4 indexed citations
7.
Khaloo, Pegah, Hamid Alemi, Michael J. Blaha, et al.. (2018). Ambulatory blood pressure monitoring and diabetes complications. Medicine. 97(38). e12185–e12185. 23 indexed citations
8.
Yaseri, Mehdi, Mohsen Afarideh, Mostafa Hosseini, et al.. (2017). Zero and Five End-Digit Preference and Blood Pressure Quality of Care Revisited.. PubMed. 20(10). 633–639. 3 indexed citations
9.
Ghajar, Alireza, et al.. (2017). l -Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Child and Adolescent Psychopharmacology. 28(1). 74–81. 26 indexed citations
10.
Noshad, Sina, Mona Shahriari, Mohsen Afarideh, et al.. (2017). Inverse Association of Peripheral Orexin-A with Insulin Resistance in Type 2 Diabetes Mellitus: A Randomized Clinical Trial. The Review of Diabetic Studies. 14(2-3). 301–310. 12 indexed citations
11.
Mohammadi, Seyed-Farzad, et al.. (2017). Obesity and Density of the Crystalline Lens: Revisiting a Growing Dilemma. PubMed. 2(1). 1–8. 4 indexed citations
12.
Abbasi, Mehrshad, Vajiheh Aghamollaii, Mona Ahmadi, et al.. (2017). Potential diagnostic value of 131 I-MIBG myocardial scintigraphy in discrimination between Alzheimer disease and dementia with Lewy bodies. Clinical Neurology and Neurosurgery. 163. 163–166. 8 indexed citations
13.
Esteghamati, Alireza, Koorosh Etemad, Jalil Koohpayehzadeh, et al.. (2016). Awareness, Treatment and Control of Pre-hypertension and Hypertension among Adults in Iran.. PubMed. 19(7). 456–64. 38 indexed citations
14.
Esteghamati, Alireza, et al.. (2016). Serum fibroblast growth factor 21 concentrations in type 2 diabetic retinopathy patients. Annales d Endocrinologie. 77(5). 586–592. 21 indexed citations
15.
Ghajar, Alireza, Leila Jahangard, Nasrin Matinnia, et al.. (2016). Crocus sativus L. versus Citalopram in the Treatment of Major Depressive Disorder with Anxious Distress: A Double-Blind, Controlled Clinical Trial. Pharmacopsychiatry. 50(4). 152–160. 78 indexed citations
16.
Afarideh, Mohsen, et al.. (2016). Visual, keratometric and corneal biomechanical changes after intacs SK implantation for moderate to severe keratoconus. Journal of Ophthalmic and Vision Research. 11(1). 17–17. 14 indexed citations
17.
Khajeh, Elias, Nekoo Panahi, Mohsen Afarideh, et al.. (2016). Plasma Apelin and Asymmetric Dimethylarginine (ADMA) Levels Shortly After Laparoscopic Greater Curvature Plication. Obesity Surgery. 27(6). 1596–1603. 3 indexed citations
18.
Afarideh, Mohsen, et al.. (2016). Raised serum 25-hydroxyvitamin D levels in patients with active diabetic foot ulcers. British Journal Of Nutrition. 115(11). 1938–1946. 32 indexed citations
19.
Afarideh, Mohsen, Zahra Aryan, Alireza Ghajar, et al.. (2016). Complex association of serum alanine aminotransferase with the risk of future cardiovascular disease in type 2 diabetes. Atherosclerosis. 254. 42–51. 21 indexed citations
20.
Hoseini, Seyed Mehdi, Ali Kalantari‐Hesari, Mohsen Afarideh, et al.. (2014). Evaluation of plasma MMP-8, MMP-9 and TIMP-1 identifies candidate cardiometabolic risk marker in metabolic syndrome: results from double-blinded nested case–control study. Metabolism. 64(4). 527–538. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026